A growing number of natural products, as well as synthetic and semi-synthetic molecules, have been found to mitigate AD pathology by modulating the PI3K/AKT pathway (Kumar and Bansal, 2022; Huang et al., 2018). The gene discussed is AKT1; the disease is Alzheimer disease.